Bio-IT World Announces 2007 “Best of Show” Awards



BOSTON – The winners of the Bio-IT World Conference & Expo “Best of Show Awards” for 2007 were announced this week. The four winning entries were:

  • Tessella: Adaptive Trials Simulation Toolkit v 1.0
  • Ingenuity Systems: Ingenuity Pathways Analysis 5.0
  • Isilon Systems: Isilon IQ with OneFS 4.5
  • Rescenris: CERF v 2.6

Following submission of all the new products being presented at the 2007 show, a team of editors and expert judges selected three finalists in each of four categories. During the event, the finalists met individually with the panel of judges, led by Bio-IT World executive editor John Russell, before the judges retired to deliberate the winners in each category. Criteria included technical merit, functionality and innovation, as well as the quality of the live presentations on the show floor. The winners received their awards at a ceremony held at Boston’s World Trade Center during the event.

Below are further details on the four winning entries at this year’s show:

  • eClinical Technology

Tessella: Adaptive Trials Simulation Toolkit  v 1.0

The Tessella ‘Adaptive Trials Simulation Toolkit’ contains a range of adaptive clinical trial models for simulating different adaptive methods from phase 1 through to phase 3. The first release includes a Bayesian model for phase 2 trials called ‘NDLM dose finder’, and a ‘Seamless Phase 2/3 Simulator’.

The toolkit is currently implemented as a desktop application with a GUI component and separate computational models. The GUI allows the user to easily set up the specification for their trial, choose their design options and specify the different scenarios over which the design should be simulated. Having run the simulations, the GUI displays graphs and charts of the summary data so the expected operating characteristics of the design can be studied. The current implementation runs the simulations on the same hardware running the GUI. Future versions should allow simulations to be run on alternative hardware such as a centrally provided computing resource.

  • Life Science Software & Informatics

Ingenuity Systems; IPA 5.0

IPA enables researchers to analyze complex biological and chemical systems at the core of life science research. New enhancements provide powerful new capabilities to address emerging industry needs. IPA-Tox overcomes the data interpretation hurdle to deliver a focused toxicity assessment of your candidate compounds, and IPA-Biomarker uses filters to identify the most promising biomarker candidates and reveals the underlying mechanistic connection between biomarkers and disease. These capabilities integrate smoothly with IPA’s core analysis capabilities, which identify the pathways, regulatory networks, and biological processes most perturbed in your dataset.

  • IT Infrastructure

Isilon Systems; Isilon IQ with OneFS 4.5

Isilon IQ delivers the first single file system that unifies and provides instant and ubiquitous access to digital content and unstructured data, eliminating the cost and complexity barriers of traditional storage architectures. OneFS 4.5 is an operating system that powers all of Isilon’s IQ family of clustered storage systems. The release of OneFS 4.5 software marks the industry’s first clustered storage system to deliver one Petabyte of capacity and 10 Gigabytes per second of performance in a single file system and single volume.

  • Notebooks & LIMS

Rescentris; CERF v 2.6 

Rescentris’ Collaborative Electronic Research Framework (CERF) is a secure, 21CFR11-compliant enterprise scientific information system designed for managing and sharing information in life sciences organizations. CERF combines an electronic lab notebook (ELN) with scientific content management, an extensible knowledge and data integration framework, and a science-driven informatics platform. Its intuitive cross-platform desktop interface allows scientists to organize and unify access to personal and shared content, applications, and databases. In addition to being first to market with an ELN for Biology, CERF is the only ELN system built on semantic web internet technology.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .